Graduate School of Life Sciences, Tohoku University, Katahira, Aoba-ku, Sendai, Japan.
Chemistry. 2012 Oct 1;18(40):12681-9. doi: 10.1002/chem.201201211. Epub 2012 Aug 22.
Covalently linked vancomycin dimers have attracted a great deal of attention among researchers because of their enhanced antibacterial activity against vancomycin-resistant strains. However, the lack of a clear insight into the mechanisms of action of these dimers hampers rational optimization of their antibacterial potency. Here, we describe the synthesis and antibacterial activity of novel vancomycin dimers with a constrained molecular conformation achieved by two tethers between vancomycin units. Conformational restriction is a useful strategy for studying the relationship between the molecular topology and biological activity of compounds. In this study, two vancomycin units were linked at three distinct positions of the glycopeptide (vancosamine residue (V), C terminus (C), and N terminus (N)) to form two types of novel vancomycin cyclic dimers. Active NC-VV-linked dimers with a stable conformation as indicated by molecular mechanics calculations selectively suppressed the peptidoglycan polymerization reaction of vancomycin-resistant Staphylococcus aureus in vitro. In addition, double-disk diffusion tests indicated that the antibacterial activity of these dimers against vancomycin-resistant enterococci might arise from the inhibition of enzymes responsible for peptidoglycan polymerization. These findings provide a new insight into the biological targets of vancomycin dimers and the conformational requirements for efficient antibacterial activity against vancomycin-resistant strains.
共价连接的万古霉素二聚体因其对耐万古霉素菌株的增强抗菌活性而引起了研究人员的极大关注。然而,由于缺乏对这些二聚体作用机制的清晰了解,限制了对其抗菌效力的合理优化。在这里,我们描述了通过万古霉素单元之间的两个连接体实现的具有约束分子构象的新型万古霉素二聚体的合成和抗菌活性。构象限制是研究化合物的分子拓扑结构与生物活性之间关系的有用策略。在这项研究中,两个万古霉素单元连接在糖肽的三个不同位置(vancosamine 残基(V)、C 末端(C)和 N 末端(N))上,形成两种新型万古霉素环状二聚体。通过分子力学计算表明具有稳定构象的活性 NC-VV 连接二聚体选择性抑制耐万古霉素金黄色葡萄球菌体外的肽聚糖聚合反应。此外,双碟扩散试验表明,这些二聚体对耐万古霉素肠球菌的抗菌活性可能源于对负责肽聚糖聚合的酶的抑制。这些发现为万古霉素二聚体的生物靶标以及针对耐万古霉素菌株的有效抗菌活性的构象要求提供了新的见解。